Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleProceedings of the Joint International Symposium “Vitamin D in Prevention and Therapy” and “Biologic Effects of Light”, 5-7 June, 2019 (Homburg/Saar, Germany)R

Sunbeds and Melanoma Risk: Many Open Questions, Not Yet Time to Close the Debate

JÖRG REICHRATH, PELLE G. LINDQVIST, STEFAN PILZ, WINFRIED MÄRZ, WILLIAM B. GRANT, MICHAEL F. HOLICK and FRANK R. DE GRUIJL
Anticancer Research January 2020, 40 (1) 501-509; DOI: https://doi.org/10.21873/anticanres.13978
JÖRG REICHRATH
1Center for Clinical and Experimental Photodermatology, The Saarland University Hospital, Homburg, Germany
2Department of Dermatology, The Saarland University Hospital, Homburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Joerg.reichrath{at}uks.eu
PELLE G. LINDQVIST
3Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN PILZ
4Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WINFRIED MÄRZ
5Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
6Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology), Medical Faculty Mannheim, Ruperto-Carola University of Heidelberg, Heidelberg, Germany
7Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLIAM B. GRANT
8Sunlight, Nutrition and Health Research Center, San Francisco, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL F. HOLICK
9Boston University Medical Center, Boston, MA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK R. DE GRUIJL
10Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Intensive scientific debate is ongoing about whether moderate solarium use increases melanoma risk. The authors of some recent publications demand the debate be closed and propose “actions against solarium use for skin cancer prevention” because new studies have convincingly demonstrated causality. This minireview aims to investigate whether those demands are sufficiently supported by present scientific knowledge and comply with the principles of evidence-based medicine. Materials and Methods: We performed a systematic literature search (through June 2019; PubMed, ISI Web of Science) to identify publications investigating how solarium use affects melanoma risk. Results: We found no studies that demonstrate a causal relationship between moderate solarium use and melanoma risk. Results of cohort and case–control studies published to date, including recent investigations, do not prove causality, and randomized controlled trials providing unequivocal proof are still lacking. Moreover, the overall quality of observational studies is low as a result of severe limitations (including unobserved or unrecorded confounding), possibly leading to bias. We also disagree with recent claims that Hill's criteria for the epidemiological evidence of a causal relationship between a potential causal factor and an observed effect are fulfilled in regard to the conclusion that moderate solarium use per se would increase melanoma risk Conclusion: Current scientific knowledge does not demonstrate a causal relationship between moderate solarium use and melanoma risk. Therefore, the debate is not closed.

  • Sunbeds
  • melanoma
  • solarium
  • tanning
  • Hill criteria

An intensive scientific debate is ongoing about whether solarium use increases melanoma risk (1-34). We previously published a meta-analysis of observational studies investigating the association of sunbed use with melanoma, concluding that no convincing evidence exists that moderate solarium use may increase melanoma risk (8). However, some recent publications (1-6) claim that new studies that show associations between solarium use and melanoma risk have convincingly demonstrated causality, and demand the debate be closed (1), and propose “actions against solarium use for skin cancer prevention” (1). In particular, Suppa and Gandini in their review address the following: a) New studies investigating the influence of age at first sunbed exposure on melanoma risk, b) novel association of sunbed exposure with risk of melanoma at different body sites, c) new data about the relevance of sunbed use for the development of additional primary melanomas, d) the most recent findings of how many melanomas are attributable to sunbed use, e) new data about the association of indoor tanning with melanoma risk factors, f) a recent analysis of the economic burden of sunbed use, and g) the recent debate over whether indoor tanning contributes to melanoma (1). Those authors conclude that “all the epidemiological criteria for causality apply to the relationship between sunbed use and melanoma” and that “the debate over whether sunbed use contributes to melanoma risk should be considered definitely closed.” This work aims to demonstrate whether the criticism previously addressed by us (8, 9) and others (7) has been adequately addressed in those publications (1-3, 5, 6), whether their conclusions are sufficiently supported by scientific knowledge, and whether they are in agreement with generally accepted principles of evidence-based medicine. We wish to point out that we make no advice regarding sunbed use in our work, but simply aim to critically appraise whether or not the scientific evidence is sufficient to claim that solarium use causally increases melanoma risk without any uncertainties that may be a reason for questioning this “black and white” statement.

Materials and Methods

To update the publications included in our previous meta-analysis (8), we performed a systematic database search (PubMed and ISI Web of Science, from 15 January 2016 until June 2019) to identify any literature published in English or German that investigated the effect of solarium use on melanoma risk (JR). We used the key words “solarium”, “sunbed”, “indoor tanning”, “tanning salon”, “artificial UV”, and “melanoma”. Identified articles were cross-referenced for additional publications missed by the database search. In addition to the recent studies identified in our database search, we also considered the findings of relevant earlier studies included in our previous meta-analysis (8).

Results and Discussion

The literature search process identified 103 articles. Depending on the content, title, abstract and/or full text were analyzed to identify relevant new findings. The updated information that these articles gave is summarized in the following paragraphs. Overall, we found no studies that demonstrate a causal relationship between moderate solarium use and melanoma risk.

Our analysis of the report of Suppa and Gandini (1) revealed severe weaknesses (Table I). The criticism previously addressed by us (8, 9) and others (7) has not been adequately addressed in the report of Suppa and Gandini (1) or by others (2, 3, 5, 6). The conclusions reported in those publications (1-3, 5, 6) are not sufficiently supported by present scientific knowledge and therefore are not in agreement with generally accepted principles of evidence-based medicine.

Randomized controlled trials are able to provide unequivocal proof of a causal relationship between moderate solarium use and melanoma risk. However, such trials are lacking [reviewed in (8, 9) for various reasons: a) they are unfeasible-they take too long, are too costly, and too demanding on compliance; and b) they would now be considered unethical by many, as voiced by Suppa and Gandini (1). The results of cohort and case–control studies do not prove causality [reviewed in (8, 9)], not even by the Hill criteria (22), contrary to what is suggested by Suppa and Gandini (1) (see below). Moreover, the overall quality of those observational studies and the resulting evidence levels are low as a result of severe limitations (including unobserved or unrecorded confounding), leading to bias [reviewed in (8, 9)].

In most studies published to date, many of the confounding factors, including sun exposure, sunburn, and skin type, have not been adequately and systematically recorded and adjusted for [reviewed in (8, 9)]. As pointed out in our previous meta-analysis (8), only a few studies published so far reported odds ratios (ORs) adjusted for the same confounding factors. As many as 35.5% (n=11) of all (n=31) studies included in that meta-analysis (8) did not account for a single confounder. The remaining studies (n=20) adjusted mainly for age (n=15), sex (n=11), and skin color (n=11). Fewer studies adjusted for hair color (n=10), sun exposure (n=8), sunburn (n=8), family history of melanoma (n=7), nevi (n=7), freckles (n=5), and education (n=5). Moreover, individual confounders were assessed differently across studies included in that meta-analysis (8) and were only partly comparable.

In this context, risk estimates (e.g. ORs) as given in meta-analyses published to date, including those by Burgard and colleagues (8), Boniol and colleagues (11) and Colantonio and colleagues (7), might well have been affected by the issues of lack of standardization in terms of confounding factors for sunbed studies [8,9] and could well be obtained through the scenario indicated before (8, 9): Moderate sunbed use has no effect on melanoma risk, but an “unhealthy lifestyle” (e.g. extensive sunbathing, alcohol, smoking) resulted in an inflated OR of 1.2 in association with sunbed use [“sun worshippers” and individuals with an unhealthy lifestyle go more often to tanning salons (8, 9)].

The gap between sunbed studies and earlier studies on risk of sun exposure remains remarkable. Confounding caused by exposure to the sun – the major UV source – is often neglected or corrected for inadequately. Most often, such work lacks a proper analysis of covariance (collinearity or other) to eliminate a possible dominance of sun over sunbed exposure due to an a priori highly plausible strong correlation between sunbed use and sunbathing; OR=2 to 7 for sunbathing among sunbed users versus nonusers (12-14). As pointed out in a recent French study (15), sunbeds were estimated to have only a minor contribution to melanoma incidence (1.5% in men and 4.6% in women) compared with the sun (83%); that is, sunbeds were not likely to be a major driver of the increase in melanoma incidence. Moreover, the authors noted that disentangling risk from use of sunbeds from that of the sun is difficult [anecdotal attribution of melanoma to sunbed use is often offset by excessive sunbathing, as exemplified by an Australian publicity campaign to regulate solaria (16)]. The importance of solar UV exposure and sunburn for melanoma development is reflected by the frequency of melanomas that occur after the diagnosis of a cutaneous melanoma, reported to range from 8.2% of previously diagnosed melanoma in European countries to 23% in countries with more intense ambient solar UV radiation (34-42). Earlier studies identified the number of sunburns as a good proxy of “at risk” sun exposure in relation to melanoma (17, 18). Virtually all studies on sunbed and melanoma fail to use that proper proxy of effective UV dosimetry, except for two studies that confirmed a strong relationship between UV burns and melanoma risk (19, 20). That finding would imply that UV burns specifically increase melanoma risk, but it should be considered that genuine sunburn is far more common than UV burns from sunbeds. The confounding effects of sun exposure and impact of UV burns would also be compelling reasons why melanoma risk in relation to sunbed use varies so strongly between studies: Meta-analyses of European studies showed no net significant melanoma risk associated with sunbed use, in contrast to U.S. and Australian studies (7, 8).

We also disagree with the conclusion of Suppa and Gandini (1) that the criteria defined by Hill (22) [or as modified by Weed and Gorelic (23)] to provide epidemiological evidence of a causal relationship between a potential cause and an observed effect are fulfilled for the inference that moderate solarium use per se increases melanoma risk (Table I). The following criteria are not fulfilled for the relationship between moderate solarium use and melanoma risk:

  • Consistency (consistent findings observed by different persons in different places with different samples strengthen the likelihood of an effect)

  • Specificity (causation is likely if there is a very specific population at a specific site and disease with no other likely explanation)

  • Plausibility (a plausible mechanism between cause and effect is helpful in determining causality)

  • Coherence (coherence between epidemiological and laboratory findings increases the likelihood of a causal effect)

  • Experiment (experimental evidence is helpful in determining causality)

Therefore, based on Hill's criteria, the evidence does not support causality. Consistency and specificity are not fulfilled for many reasons, including the obvious difficulties of confounding factors. In a recent meta-analysis, subgroup analyses for studies performed in Europe, studies with low risk of bias, and studies with recruitment between 1991 and 1999 showed no association between melanoma risk and solarium use (ever vs. never) (8). The lack of association in the subgroup analysis is unlikely to be caused by a lack of power, for example, because the number of participants in studies performed in Europe is much greater than in U.S. studies. The lack of association in studies performed in Europe may be due to several factors. Firstly, as outlined above, the role of solar UV exposure represents a major confounding factor that is difficult to document or adjust for and that may well in part explain why latitude-dependent variations in melanoma risk in association with sunbed arise (e.g. due to shifts in effects from sunburns).

However, other region-specific factors, which include technical differences in solarium devices, must also be taken into account, as must skin type, also an important confounding factor. Since 2008, solarium devices in Europe and Oceania (Australia and New Zealand) are restricted in intensity to a UV index of 12 and 36 (which was 60 before 2002), respectively. In contrast, the intensity of a U.S. solarium is not restricted, but a maximum recommended exposure time is often given. In a previous meta-analysis, another observation of sensitivity and subgroup analyses was the finding that the recruitment period strongly affected the association of melanoma risk with solarium use (17). For recruitment before 1991, a higher OR was found than for recruitment from 1991 to 1999 or since 2000. This observation might be due to changes in operation and technical modifications of UV-emitting devices (about two decades ago, the solarium industry started to produce devices with higher pressure bulbs emitting larger doses of long-wave UVA). Moreover, as shown in our recent meta-analysis (8), many published studies most likely overestimated the association of melanoma risk with solarium use.

A large body of evidence from epidemiological and animal studies demonstrates no increase in melanoma risk after chronic (moderate) UV exposure (24-31). Many studies show that suberythemal chronic exposure to the sun may even be protective and that outdoor workers may have a reduced risk of melanoma (18, 27-30). Driver mutations in the B-rapidly accelerated fibrosarcoma (BRAF) gene or in other important drivers of melanomagenesis do not carry the specific UV signature [mutations in BRAF are similar to those found in guanine nucleotide-binding protein subunit alpha-11 (GNA11) and GNAQ driver genes in uveal melanomas from UV-protected parts of the inner eye (31)]. Initiating melanoma by UV exposure in mice without predisposition by an activated oncogene proved difficult [with few exceptions, e.g. by neonatal exposure of inhibitor of cyclin-dependent kinase 4-alternate open reading frame-null xeroderma pigmentosum, complementation group C-null (Ink4a-Arf−/−Xpc−/−) mice (32) and incidentally successful, 3/20, with repeated sunburn exposure (33)].

View this table:
  • View inline
  • View popup
Table I.

Tabular overview of our critical appraisal of the review of Suppa and Gandini (1).

The results of many recent investigations clearly argue against the hypothesis that moderate solarium use may increase melanoma risk. Unfortunately, however, the review of Suppa and Gandini (1) does not adequately consider those studies. For example, the retrospective case–control study of Müller and colleagues investigated risk factors for subsequent primary melanomas after the diagnosis of a cutaneous melanoma in Austria (1,648 participants with histologically verified cutaneous melanoma, including 1,349 with single and 299 with multiple primary melanomas) (34). Suppa and Gandini mentioned the study, but the main findings were not adequately presented (1). In that study, solarium use was not associated with an increased but rather a reduced risk for developing melanoma (OR=0.71; 95% confidence interval=0.51–0.99; p=0.04) (34). Those findings indicate that solarium use may even have a protective effect.

In summary, the main conclusions drawn by Suppa and Gandini (1) and others (2-6) are scientifically not proven and are not in accordance with generally accepted principles of evidence-based medicine. They are not in line with recommendations of the Oxford Centre for Evidence-based Medicine (21). Furthermore, as outlined in this minireview (Table I) and previously (9), the conclusions do not fulfill Hill's criteria for plausibility in a biological system (22). Other researchers added the ruling out of confounding factors and bias (23). The review of Suppa and Gandini (1), as well as recent publications by others (2, 3, 5, 6) are therefore not correct in reaching their conclusions, and the debate is not closed.

Footnotes

  • Authors' Contributions

    Literature search: JR. Data analysis: JR, PL, WM, SP, MH, WG, FDG. Article preparation: JR, PL, WM, SP, MH, WG, FDG.

  • This article is freely accessible online.

  • Conflicts of Interest

    William B. Grant received funding from Canadian, European, and U.S. indoor tanning companies and organizations during the period 2005 to 2014. Saarland University (with JR being a responsible project coordinator) received research funding from the Jörg Wolff foundation.

  • Received November 13, 2019.
  • Revision received November 29, 2019.
  • Accepted December 3, 2019.
  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Suppa M,
    2. Gandini S
    : Sunbeds and melanoma risk: Time to close the debate. Curr Opin Oncol 31(2): 65-71, 2019. PMID: 30676536. DOI: 10.1097/CCO.0000000000000507
    OpenUrlPubMed
  2. ↵
    1. Yared W,
    2. Boonen B,
    3. McElwee G,
    4. Ferguson M
    : Cancer league actions against sunbed use for skin cancer prevention. J Eur Acad Dermatol Venereol 33(Suppl 2): 97-103, 2019. PMID: 30811700. DOI: 10.1111/jdv.15319
    OpenUrlPubMed
  3. ↵
    1. Augustin M,
    2. Del Marmol V
    : Sunbeds: An international common concern. J Eur Acad Dermatol Venereol 33(Suppl 2): 5, 2019. PMID: 30811697. DOI: 10.1111/jdv.15410
    OpenUrl
    1. Krensel M,
    2. Schäfer I,
    3. Augustin M
    : Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe. J Eur Acad Dermatol Venereol 33(Suppl 2): 46-56, 2019. PMID: 30811692. DOI: 10.1111/jdv.15313
    OpenUrlPubMed
  4. ↵
    1. Calzavara-Pinton PG,
    2. Arisi M,
    3. Wolf P
    : Sunbeds and carcinogenesis: the need for new regulations and restrictions in Europe from the Euromelanoma perspective. J Eur Acad Dermatol Venereol 33(Suppl 2): 104-109, 2019. PMID: 30811688. DOI: 10.1111/jdv.15314
    OpenUrlPubMed
  5. ↵
    1. Del Marmol V,
    2. Stratigos A,
    3. Calzavara-Pinton P,
    4. Augustin M
    : Sunbed use in Europe: Time for information. J Eur Acad Dermatol Venereol 33(Suppl 2): 3, 2019. PMID: 30811687. DOI: 10.1111/jdv.15310
    OpenUrl
  6. ↵
    1. Colantonio S,
    2. Bracken MB,
    3. Beecker J
    : The association of indoor tanning and melanoma in adults: systematic review and meta-analysis. J Am Acad Dermatol 70: 847-857, 2014. PMID: 24629998. DOI: 10.1016/j.jaad.2013.11.050
    OpenUrlCrossRefPubMed
  7. ↵
    1. Burgard B,
    2. Schöpe J,
    3. Holzschuh I,
    4. Schiekofer C,
    5. Reichrath S,
    6. Stefan W,
    7. Pilz S,
    8. Ordonez-Mena J,
    9. März W,
    10. Vogt T,
    11. Reichrath J
    : Solarium use and risk for malignant melanoma: Meta-analysis and evidence-based medicine systematic review. Anticancer Res 38(2): 1187-1199, 2018. PMID: 29374757.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Reichrath J,
    2. Lindqvist PG,
    3. DE Gruijl FR,
    4. Pilz S,
    5. Kimball SM,
    6. Grant WB,
    7. Holick MF
    : A Critical appraisal of the recent reports on Sunbeds from the European Commission's Scientific Committee on Health, Environmental and Emerging Risks and from the World Health Organization. Anticancer Res 38(2): 1111-1120, 2018. PMID: 29374748.
    OpenUrlAbstract/FREE Full Text
    1. Reichrath J,
    2. Pilz S,
    3. März W
    : Kausaler Zusammenhang zwischen Solariennutzung und Melanomrisiko nicht gesichert. Dtsch Arztebl Int 116(8): 135, 2019. DOI: 10.3238/arztebl.2019.0135a
    OpenUrl
  9. ↵
    1. Boniol M,
    2. Autier P,
    3. Boyle P,
    4. Gandini S
    : Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345: e4757, 2012. PMID: 22833605. DOI: 10.1136/bmj.e4757
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Ezzedine K,
    2. Malvy D,
    3. Mauger E,
    4. Nageotte O,
    5. Galan P,
    6. Hercberg S,
    7. Guinot C
    : Artificial and natural ultraviolet radiation exposure: beliefs and behaviour of 7200 French adults. J Eur Acad Dermatol Venereol 22(2): 186-194, 2008. PMID: 18211412. DOI: 10.1111/j.1468-3083.2007.02367.x
    OpenUrlPubMed
    1. Gordon LG,
    2. Hirst NG,
    3. Green AC,
    4. Neale RE
    : Tanning behaviors and determinants of solarium use among indoor office workers in Queensland, Australia. J Health Psychol 17(6): 856-865, 2012. PMID: 22131168. DOI: 10.1177/1359105311427476
    OpenUrlCrossRefPubMed
  11. ↵
    1. Westerdahl J,
    2. Ingvar C,
    3. Masback A,
    4. Jonsson N,
    5. Olsson H
    : Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 82(9): 1593-1599, 2000. PMID: 10789730.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Arnold M,
    2. Kvaskoff M,
    3. Thuret A,
    4. Guénel P,
    5. Bray F,
    6. Soerjomataram I
    : Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds. J Eur Acad Dermatol Venereol 32(10): 1681-1686, 2018. PMID: 29706005. DOI: 10.1111/jdv.15022
    OpenUrlPubMed
  13. ↵
    1. MacKenzie R,
    2. Imison M,
    3. Chapman S,
    4. Holding S
    : Mixed messages and a missed opportunity: Australian news media coverage of Clare Oliver's campaign against solaria. Med J Aust 189(7): 371-374, 2008. PMID: 18837679.
    OpenUrlPubMed
  14. ↵
    1. Gandini S,
    2. Sera F,
    3. Cattaruzza MS,
    4. Pasquini P,
    5. Picconi O,
    6. Boyle P,
    7. Melchi CF
    : Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41(1): 45-60, 2005. PMID: 15617990.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Elwood JM,
    2. Jopson J
    : Melanoma and sun exposure: An overview of published studies. Int J Cancer 73(2): 198-203, 1997. PMID: 9335442.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Lazovich D,
    2. Vogel RI,
    3. Berwick M,
    4. Weinstock MA,
    5. Anderson KE,
    6. Warshaw EM
    : Indoor tanning and risk of melanoma: A case–control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 19(6): 1557-1568, 2010. PMID: 20507845. DOI: 10.1158/1055-9965.EPI-09-1249
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Autier P,
    2. Doré JF,
    3. Lejeune F,
    4. Koelmel KF,
    5. Geffeler O,
    6. Hille P,
    7. Cesarini JP,
    8. Lienard D,
    9. Liabeuf A,
    10. Joarlette M,
    11. for the EORTC Melanoma Cooperative Group
    : Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An EORTC multicenter Case–control study in Belgium, France and Germany. Int J Cancer 58(6): 809-813, 1994. PMID: 7927872. DOI: 10.1002/ijc.2910580610
    OpenUrlCrossRefPubMed
  18. ↵
    1. Oxford Centre for Evidence-based Medicine – Levels of Evidence
    (March 2009). Available at: htpp://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
  19. ↵
    1. Hill AB
    : The environment and disease: Association or causation? Proc R Soc Med 58: 295-300, 1965. PMID: 14283879.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Weed DL,
    2. Gorelic LS
    : The practice of causal inference in cancer epidemiology. Cancer Epidemiol Biomarkers Prev 5: 303-311, 1996. PMID: 8722223.
    OpenUrlAbstract
  21. ↵
    1. Jhappan C,
    2. Noonan FP,
    3. Merlino G
    : Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22(20): 3099-3112, 2003. PMID: 1278928.
    OpenUrlCrossRefPubMed
    1. Noonan FP,
    2. Zaidi MR,
    3. Wolnicka-Glubisz A,
    4. Anver MR,
    5. Bahn J,
    6. Wielgus A,
    7. Cadet J,
    8. Douki T,
    9. Mouret S,
    10. Tucker MA,
    11. Popratiloff A,
    12. Merlino G,
    13. De Fabo EC
    : Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Nat Commun 3: 884, 2012. PMID: 22673911. DOI: 10.1038/ncomms1893
    OpenUrlCrossRefPubMed
    1. Reichrath J,
    2. Rass K
    : Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update. Adv Exp Med Biol 810: 208-233, 2014. PMID: 25207368.
    OpenUrlPubMed
  22. ↵
    1. Elwood JM,
    2. Gallagher RP,
    3. Hill GB,
    4. Pearson JC
    : Cutaneous melanoma in relation to intermittent and constant sun exposure–The western Canada melanoma study. Int J Cancer 35: 427-433, 1985. PMID: 3988369.
    OpenUrlPubMed
    1. Gass R,
    2. Bopp M
    : Mortality from malignant melanoma: Epidemiological trends in Switzerland. Schweiz Rundsch Med Prax 94(34): 1295-1300, 2005. PMID: 16170998. DOI: 10.1024/0369-8394.94.34.1295
    OpenUrl
    1. Kennedy C,
    2. Bajdik CD,
    3. Willemze R,
    4. De Gruijl FR,
    5. Bouwes Bavinck JN
    : Leiden Skin Cancer Study. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 120(6): 1087-1093, 2003. PMID: 12787139.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Grant WB
    : Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordical appraisal of the recent reports o countries. Dermatoendocrinol 4(2): 203-211, 2012. PMID: 22928078. DOI: 10.4161/derm.20965
    OpenUrlPubMed
  24. ↵
    1. de Lange MJ,
    2. Razzaq L,
    3. Versluis M,
    4. Verlinde S,
    5. Dogrusöz M,
    6. Böhringer S,
    7. Marinkovic M,
    8. Luyten GP,
    9. de Keizer RJ,
    10. de Gruijl FR,
    11. Jager MJ,
    12. van der Velden PA
    : Distribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanism. PLoS One 10(9): e0138002, 2015. PMID: 26368812. DOI: 10.1371/journal.pone.0138002
    OpenUrlPubMed
  25. ↵
    1. Yang G,
    2. Curley D,
    3. Bosenberg MW,
    4. Tsao H
    : Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer Res 67(12): 5649-5657, 2007. PMID: 17575131,
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. van Schanke A,
    2. van Venrooij GM,
    3. Jongsma MJ,
    4. Banus HA,
    5. Mullenders LH,
    6. van Kranen HJ,
    7. de Gruijl FR
    : Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures. Cancer Res 66(5): 2608-2615, 2006. PMID: 16510579.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Müller C,
    2. Wendt J,
    3. Rauscher S,
    4. Sunder-Plassmann R,
    5. Richtig E,
    6. Fae I,
    7. Fischer G,
    8. Okamoto I
    : Risk factors of subsequent primary melanomas in Austria. JAMA Dermatol 155(2): 188-195, 2019. PMID: 30566178. DOI: 10.1001/jamadermatol.2018.4645
    OpenUrlPubMed
    1. Ferrone CR,
    2. Ben Porat L,
    3. Panageas KS,
    4. Berwick M,
    5. Halpern AC,
    6. Patel A,
    7. Coit DG
    : Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 294(13): 1647-1654, 2005. PMID: 16204664. DOI: 10.1001/jama.294.13.1647
    OpenUrlCrossRefPubMed
    1. Rowe CJ,
    2. Law MH,
    3. Palmer JM,
    4. MacGregor S,
    5. Hayward NK,
    6. Khosrotehrani K
    : Survival outcomes in patients with multiple primary melanomas. J Eur Acad Dermatol Venereol 29(11): 2120-2127, 2015. PMID: 25864459. DOI: 10.1111/jdv.13144
    OpenUrlPubMed
    1. Manganoni AM,
    2. Farisoglio C,
    3. Tucci G,
    4. Facchetti F,
    5. Calzavara Pinton PG
    : The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: A report of 47 cases. J Eur Acad Dermatol Venereol 21(10): 1333-1336, 2007. PMID: 24843434. DOI: 10.1111/j.1468-3083.2007.02263.x
    OpenUrlPubMed
    1. Johnson TM,
    2. Hamilton T,
    3. Lowe L
    : Multiple primary melanomas. J Am Acad Dermatol 39(3): 422-427, 1998. PMID: 9738776. DOI: 10.1016/S0190-9622(98)70318-4
    OpenUrlCrossRefPubMed
    1. Stam-Posthuma JJ,
    2. van Duinen C,
    3. Scheffer E,
    4. Vink J,
    5. Bergman W
    : Multiple primary melanomas. J Am Acad Dermatol 44(1): 22-27, 2001. PMID: 11148472. DOI: 10.1067/mjd.2001.110878
    OpenUrlCrossRefPubMed
    1. Carli P,
    2. De Giorgi V,
    3. Chiarugi A,
    4. Stante M,
    5. Giannotti B
    : Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol 41(9): 583-585, 2002. PMID: 12358828. DOI: 10.1046/j.1365-4362.2002.01605.x
    OpenUrlPubMed
    1. Blackwood MA,
    2. Holmes R,
    3. Synnestvedt M,
    4. Young M,
    5. George C,
    6. Yang H,
    7. Elder DE,
    8. Schuchter LM,
    9. Guerry D,
    10. Ganguly A
    : Multiple primary melanoma revisited. Cancer 94(8): 2248-2255, 2002. PMID: 12001124. DOI: 10.1002/cncr.10454
    OpenUrlCrossRefPubMed
  28. ↵
    1. Titus-Ernstoff L,
    2. Perry AE,
    3. Spencer SK,
    4. Gibson J,
    5. Ding J,
    6. Cole B,
    7. Ernstoff MS
    : Multiple primary melanoma: Two-year results from a population-based study. Arch Dermatol 142(4): 433-438, 2006. PMID: 16618861. DOI: 10.1001/archderm.142.4.433
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 1
January 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Sunbeds and Melanoma Risk: Many Open Questions, Not Yet Time to Close the Debate
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Sunbeds and Melanoma Risk: Many Open Questions, Not Yet Time to Close the Debate
JÖRG REICHRATH, PELLE G. LINDQVIST, STEFAN PILZ, WINFRIED MÄRZ, WILLIAM B. GRANT, MICHAEL F. HOLICK, FRANK R. DE GRUIJL
Anticancer Research Jan 2020, 40 (1) 501-509; DOI: 10.21873/anticanres.13978

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Sunbeds and Melanoma Risk: Many Open Questions, Not Yet Time to Close the Debate
JÖRG REICHRATH, PELLE G. LINDQVIST, STEFAN PILZ, WINFRIED MÄRZ, WILLIAM B. GRANT, MICHAEL F. HOLICK, FRANK R. DE GRUIJL
Anticancer Research Jan 2020, 40 (1) 501-509; DOI: 10.21873/anticanres.13978
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Improving Photoprotection and Implications for 25(OH)D Formation
  • Relevance of Vitamin D in Melanoma Development, Progression and Therapy
Show more Proceedings of the Joint International Symposium “Vitamin D in Prevention and Therapy” and “Biologic Effects of Light”, 5-7 June, 2019 (Homburg/Saar, Germany)

Similar Articles

Keywords

  • Sunbeds
  • Melanoma
  • solarium
  • tanning
  • Hill criteria
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire